| Drug Type Bispecific antibody | 
| Synonyms- | 
| Target | 
| Action modulators | 
| Mechanism LAG3 modulators(Lymphocyte activation gene 3 protein modulators), TIM3 modulators(Hepatitis A virus cellular receptor 2 modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Solid tumor | Preclinical | - | - | 






